Literature DB >> 27116718

Immunology of Multiple Sclerosis.

Mireia Sospedra1, Roland Martin1.   

Abstract

Multiple sclerosis (MS) is considered a prototypic autoimmune disease of the central nervous system (CNS). A complex genetic background with the HLA-DR15 haplotype as the main genetic risk factor and over 100 mostly immune-related minor risk alleles as well as several environmental factors contribute to the etiology of MS. With respect to pathomechanisms, autoimmune inflammation in early MS is primarily mediated by adaptive immune responses and involves autoreactive T cells, B cells, and antibodies, while the later, chronic stages of MS are characterized by a compartmentalized immune response in the CNS with activated microglia and macrophages. A host of immune cells and mediators can contribute to the autoimmune process, but CNS-related factors such as localization of lesions, vulnerability of oligodendrocytes, neurons/axons, and secondary metabolic changes all play a role in the heterogeneous expression of the disease, including different pathologic lesion patterns, neuroimaging findings, disease courses, and severity and response to treatment. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27116718     DOI: 10.1055/s-0036-1579739

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  64 in total

1.  Tumor necrosis factor alpha (TNF-α) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis.

Authors:  Claudia Mara Ribeiro; Sayonara Rangel Oliveira; Daniela Frizon Alfieri; Tamires Flauzino; Damacio Ramón Kaimen-Maciel; Andréa Name Colado Simão; Michael Maes; Edna Maria Vissoci Reiche
Journal:  Inflamm Res       Date:  2019-09-26       Impact factor: 4.575

2.  Breakdown of multiple sclerosis genetics to identify an integrated disease network and potential variant mechanisms.

Authors:  C Joy Shepard; Sara G Cline; David Hinds; Seyedehameneh Jahanbakhsh; Jeremy W Prokop
Journal:  Physiol Genomics       Date:  2019-09-04       Impact factor: 3.107

3.  Single-cell profiling reveals GPCR heterogeneity and functional patterning during neuroinflammation.

Authors:  Denise Tischner; Myriam Grimm; Harmandeep Kaur; Daniel Staudenraus; Jorge Carvalho; Mario Looso; Stefan Günther; Florian Wanke; Sonja Moos; Nelly Siller; Johanna Breuer; Nicholas Schwab; Frauke Zipp; Ari Waisman; Florian C Kurschus; Stefan Offermanns; Nina Wettschureck
Journal:  JCI Insight       Date:  2017-08-03

4.  Prolactin is Not Associated with Disability and Clinical Forms in Patients with Multiple Sclerosis.

Authors:  Wildéa Lice de Carvalho Jennings Pereira; Tamires Flauzino; Daniela Frizon Alfieri; Sayonara Rangel Oliveira; Ana Paula Kallaur; Andrea Name Colado Simão; Marcell Alysson Batisti Lozovoy; Damacio Ramón Kaimen-Maciel; Michael Maes; Edna Maria Vissoci Reiche
Journal:  Neuromolecular Med       Date:  2019-08-31       Impact factor: 3.843

5.  Perfluorinated substances, risk factors for multiple sclerosis and cellular immune activation.

Authors:  Cecilie Ammitzbøll; Lars Börnsen; Eva Rosa Petersen; Annette Bang Oturai; Helle Bach Søndergaard; Philippe Grandjean; Finn Sellebjerg
Journal:  J Neuroimmunol       Date:  2019-03-02       Impact factor: 3.478

6.  The rs3761548 FOXP3 variant is associated with multiple sclerosis and transforming growth factor β1 levels in female patients.

Authors:  Tamires Flauzino; Daniela Frizon Alfieri; Wildea Lice de Carvalho Jennings Pereira; Sayonara Rangel Oliveira; Ana Paula Kallaur; Marcell Alysson Batisti Lozovoy; Damacio Ramón Kaimen-Maciel; Karen Brajão de Oliveira; Andrea Name Colado Simão; Edna Maria Vissoci Reiche
Journal:  Inflamm Res       Date:  2019-08-14       Impact factor: 4.575

7.  Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative/nitrosative stress biomarkers: results of multivariate and machine learning procedures.

Authors:  Tamires Flauzino; Andrea Name Colado Simão; Wildea Lice de Carvalho Jennings Pereira; Daniela Frizon Alfieri; Sayonara Rangel Oliveira; Ana Paula Kallaur; Marcell Alysson Batisti Lozovoy; Damacio Ramón Kaimen-Maciel; Michael Maes; Edna Maria Vissoci Reiche
Journal:  Metab Brain Dis       Date:  2019-07-13       Impact factor: 3.584

Review 8.  Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Authors:  Daniel Elieh-Ali-Komi; Yonghao Cao
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 9.  Laser Light Therapy in Inflammatory, Musculoskeletal, and Autoimmune Disease.

Authors:  Victoria A Wickenheisser; Emilia Marta Zywot; Emily Mary Rabjohns; Hyun Ho Lee; David S Lawrence; Teresa Kathleen Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2019-07-02       Impact factor: 4.806

Review 10.  Autologous haematopoietic stem cell transplantation for treatment of multiple sclerosis.

Authors:  Paolo A Muraro; Roland Martin; Giovanni Luigi Mancardi; Richard Nicholas; Maria Pia Sormani; Riccardo Saccardi
Journal:  Nat Rev Neurol       Date:  2017-06-16       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.